OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.425
+0.005 (0.35%)
Apr 17, 2025, 4:00 PM EDT - Market closed
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.75, with a low estimate of 2.25 and a high estimate of 3.00. The average target predicts an increase of 92.98% from the current stock price of 1.43.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +110.53% | Apr 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +110.53% | Mar 19, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +110.53% | Mar 12, 2025 |
Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +57.89% | Mar 12, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +110.53% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
669.14M
from 713.14M
Decreased by -6.17%
Revenue Next Year
723.43M
from 669.14M
Increased by 8.11%
EPS This Year
-0.32
from -0.08
EPS Next Year
-0.23
from -0.32
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 719.0M | 818.0M | 901.3M | ||
Avg | 669.1M | 723.4M | 830.7M | ||
Low | 623.8M | 616.4M | 770.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.8% | 22.2% | 24.6% | ||
Avg | -6.2% | 8.1% | 14.8% | ||
Low | -12.5% | -7.9% | 6.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.19 | -0.16 | -0.11 |
Avg | -0.32 | -0.23 | -0.11 |
Low | -0.59 | -0.43 | -0.12 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.